Chemoinformaics analysis of 2H-PYRAN-3(4H)-ONE, 6-ETHENYLDIHYDRO-2,2,6-TRIMETHYL-
| Molecular Weight | 168.236 | nRot | 1 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 8 |
| Exact Molecular Weight | 168.115 | nRing | 1 |
| Solubility: LogS | -1.147 | nHRing | 1 |
| Solubility: LogP | 1.558 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.9727 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.56 |
| Synth | 3.819 |
| Natural Product Likeliness | 2.946 |
| NR-PPAR-gamma | 0.018 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.009 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.474 |
| MDCK | 0.0000254 |
| BBB | 0.961 |
| PPB | 0.703148 |
| VDSS | 1.001 |
| FU | 0.321849 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.815 |
| CYP2c19-inh | 0.099 |
| CYP2c19-sub | 0.927 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.558 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.72 |
| CYP3a4-inh | 0.104 |
| CYP3a4-sub | 0.548 |
| CL | 7.447 |
| T12 | 0.879 |
| hERG | 0.007 |
| Ames | 0.398 |
| ROA | 0.11 |
| SkinSen | 0.171 |
| Carcinogencity | 0.467 |
| EI | 0.797 |
| Respiratory | 0.849 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.948014 |